|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of 1Oral and Maxillofacial Surgery and 2Organ Pathophysiology and Internal Medicine and 3Health Service Centre, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan
Submitted 17 June 2002 ; accepted in final form 14 March 2003
Proinflammatry cytokines, tumor necrosis factor-
combined with
interleukin-1
, induce excessive production of nitric oxide (NO) and its
cytotoxic metabolite peroxynitrite (ONOO-) via inducible nitric
oxide synthase (iNOS) in murine osteoblasts. In this study, to properly
estimate the effects of antisense DNA of iNOS on osteoblastic activity, we
produced transformed cell lines with antisense plasmid that specifically
targets the iNOS gene for potential long-lasting inhibition. Transformed
antisense cell lines were identified by 1) the detection of antisense
transcripts, 2) the attenuated expression of iNOS protein,
3) the reduction of NO synthase activity, and 4) the level
of NO production. These cell lines targeting iNOS, which showed decreased
production of both NO and ONOO-, prevented the inhibition of
osteoblastic differentiation as was assayed by the mRNA expression of type I
collagen, alkaline phosphatase, osteocalcin, and Core binding factor in the
presence of proinflammatory cytokines. Present results indicate that the
antisense DNA plasmid of iNOS is potent to reduce the cytokine-induced
inhibition of osteoblastic activity.
inducible nitric oxide synthase; antisense; peroxynitrite; osteoblast
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |